Reducing Treatment Doses in Head and Neck Cancer to Improve QOL
In this video we discuss efforts to reduce treatment doses in order to lessen long-term side effects and improve quality of life among patients with head and neck cancers.
In this video, Barbara Burtness, MD, of the Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, discusses efforts to reduce treatment doses in order to lessen long-term side effects and improve quality of life (QOL) among patients with head and neck cancers.
One of the studies she discusses was recently published in the Journal of Clinical Oncology and showed that a subgroup of patients with human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma who were treated at a reduced radiation dose (≤ 54 Gy) had reduced side effects, with fewer patients having difficulty swallowing solid food (40% vs 89%; P = .011) or impaired nutrition (10% vs 44%; P = .025).
Early Intervention, Regular Assessment Can Grasp Symptom Course for Head and Neck Cancer Therapy
April 28th 2024Nurses must increase the frequency of their assessments for early intervention of patients who undergo treatment for their head and neck cancer, in an effort to truly individualized care.
Prognostic Factors Linked With Poor Locoregional Control in Tongue Cancer
March 5th 2024Patients with factors such as lymphovascular space invasion or positive glossectomy specimen margins may be considered for adjuvant radiotherapy to optimize disease control of tongue squamous cell carcinoma.
